1. Home
  2. ESPR vs FNKO Comparison

ESPR vs FNKO Comparison

Compare ESPR & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • FNKO
  • Stock Information
  • Founded
  • ESPR 2008
  • FNKO 2017
  • Country
  • ESPR United States
  • FNKO United States
  • Employees
  • ESPR N/A
  • FNKO N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • FNKO Recreational Games/Products/Toys
  • Sector
  • ESPR Health Care
  • FNKO Consumer Discretionary
  • Exchange
  • ESPR Nasdaq
  • FNKO Nasdaq
  • Market Cap
  • ESPR 202.2M
  • FNKO 225.8M
  • IPO Year
  • ESPR 2013
  • FNKO 2017
  • Fundamental
  • Price
  • ESPR $1.20
  • FNKO $4.55
  • Analyst Decision
  • ESPR Buy
  • FNKO Buy
  • Analyst Count
  • ESPR 6
  • FNKO 4
  • Target Price
  • ESPR $6.50
  • FNKO $9.88
  • AVG Volume (30 Days)
  • ESPR 3.1M
  • FNKO 1.1M
  • Earning Date
  • ESPR 08-11-2025
  • FNKO 08-07-2025
  • Dividend Yield
  • ESPR N/A
  • FNKO N/A
  • EPS Growth
  • ESPR N/A
  • FNKO N/A
  • EPS
  • ESPR N/A
  • FNKO N/A
  • Revenue
  • ESPR $259,574,000.00
  • FNKO $1,024,890,000.00
  • Revenue This Year
  • ESPR $4.07
  • FNKO N/A
  • Revenue Next Year
  • ESPR N/A
  • FNKO $9.22
  • P/E Ratio
  • ESPR N/A
  • FNKO N/A
  • Revenue Growth
  • ESPR 12.99
  • FNKO N/A
  • 52 Week Low
  • ESPR $0.69
  • FNKO $3.50
  • 52 Week High
  • ESPR $3.94
  • FNKO $14.65
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 63.86
  • FNKO 46.33
  • Support Level
  • ESPR $1.10
  • FNKO $4.21
  • Resistance Level
  • ESPR $1.26
  • FNKO $4.72
  • Average True Range (ATR)
  • ESPR 0.08
  • FNKO 0.28
  • MACD
  • ESPR 0.02
  • FNKO -0.06
  • Stochastic Oscillator
  • ESPR 93.55
  • FNKO 35.42

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About FNKO Funko Inc.

Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: